AI assistant
Sending…
Esperion Therapeutics, Inc. — Director's Dealing 2021
Jul 8, 2021
32771_dirs_2021-07-08_a608b018-1349-4dea-9acf-f1f7818aa55c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Esperion Therapeutics, Inc. (ESPR)
CIK: 0001434868
Period of Report: 2021-06-28
Reporting Person: Foody Joanne M. (Chief Medical Officer)
More from Esperion Therapeutics, Inc.
Merger & Acquisition
2026
Jun 8
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 1
Interim / Quarterly Report
2026
May 8
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Mar 17
Regulatory Filings
2026
Mar 17
Regulatory Filings
2026
Mar 17
M&A Activity
2026
Mar 3